VEEVHealthcare · Health Information ServicesThe 30 Wall Street analysts covering Veeva Systems, Inc. hold a median 12-month price target of $235 — +2.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 77 of 100 as at 6 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Veeva Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (97): Analysts have, on balance, been raising their forecasts.
Momentum (19): The shares have been drifting down relative to others.
Size (7): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Veeva Systems, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on VEEV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +2.0% from it.
Of the 20 most recent actions, 2 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 23 July 2026 | Guggenheim | Initiates | Buy | $232 |
| 4 June 2026 | Baird | Maintains | Outperform | — |
| 4 June 2026 | Baird | Maintains | Outperform | $250 → $260 |
| 4 June 2026 | Barclays | Maintains | Overweight | $250 → $235 |
| 4 June 2026 | Barclays | Maintains | Overweight | — |
| 4 June 2026 | BMO Capital | Maintains | Market Perform | $220 → $175 |
| 4 June 2026 | BMO Capital | Maintains | Market Perform | — |
| 4 June 2026 | BTIG | Reiterates | Buy | $340 |
| 4 June 2026 | BTIG | Reiterates | Buy | — |
| 4 June 2026 | Canaccord Genuity | Maintains | Hold | — |
| 4 June 2026 | Canaccord Genuity | Maintains | Hold | $235 → $220 |
| 4 June 2026 | Citigroup | Maintains | Neutral | $176 → $190 |
| 4 June 2026 | Citigroup | Maintains | Neutral | — |
| 4 June 2026 | Evercore ISI Group | Maintains | In-Line | $240 → $185 |
| 4 June 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 4 June 2026 | Goldman Sachs | Maintains | Sell | — |
| 4 June 2026 | Goldman Sachs | Maintains | Sell | $190 → $165 |
| 4 June 2026 | Mizuho | Maintains | Outperform | — |
| 4 June 2026 | Mizuho | Maintains | Outperform | $295 → $270 |
| 4 June 2026 | Needham | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 20% of US stocks
Cheaper than 13% of US stocks
Cheaper than 21% of US stocks
Cheaper than 10% of US stocks
Higher than 66% of US stocks
Higher than 54% of US stocks
Higher than 87% of US stocks
Higher than 88% of US stocks
Higher than 88% of US stocks
Higher than 73% of US stocks
Higher than 86% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VEEV appears on the weeks it earns a place.
Veeva Systems (VEEV) rose 2.01% in the recent trading day, closing at $217.80, while the broader market dipped.
Why it matters — The stock's gain against a declining market signals relative strength and positive investor sentiment for Veeva Systems.
Veeva Systems announced it will report financial results for its fiscal 2027 second quarter, which ends July 31, 2026, after market close on August 26, 2026. The announcement was made via PRNewswire from Pleasanton, Calif.
Why it matters — VEEV watchers would care because this confirms the upcoming date for the company's quarterly earnings release, a key scheduled catalyst for investors to track.
An article on Veeva Systems notes the company has underperformed the S&P 500 despite strong fundamentals, including 16% year-over-year revenue growth, improved gross profit margins, and near-doubled cash generation. The transition from Salesforce to Vault CRM continues, though doubts about AI initiative returns and migration risks persist.
Why it matters — VEEV watchers would care because the piece highlights a tension between improving financial metrics and ongoing concerns over AI strategy returns and CRM migration execution that could influence the stock's near-term performance.
Veeva Systems shares fell 3.05% in the latest trading session, closing at $201.56 while the broader market improved.
Why it matters — The decline diverges from a rising market, which may prompt VEEV watchers to examine what caused the stock to underperform on that day.
Seeking Alpha published an article positioning Veeva Systems as a compelling buy, noting its strong growth and margin profile, robust sales execution, and attractive valuation after a near-20% YTD decline and post-earnings volatility.
Why it matters — The article highlights VEEV's favorable valuation and execution strength, which Veeva watchers would consider relevant given the stock's recent decline and potential market rotation toward lagging software names.
The 30 Wall Street analysts covering Veeva Systems, Inc. have a median 12-month price target of $235, with estimates ranging from $165 to $350. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 30 analysts covering Veeva Systems, Inc., 22 rate it a Buy, 7 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Veeva Systems, Inc. 77 out of 100 across roughly 4,600 US stocks as at 6 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 6 Aug 2026, Veeva Systems, Inc. ranks 77 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (97 of 100).
No one can know that. What the data says: the median 12-month target from 30 analysts implies +2.0% from the last close, and Ticker Nerd's factor model ranks Veeva Systems, Inc. 77 out of 100 as at 6 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Veeva Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VEEV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $165 to $350 over the next 12 months.
Veeva Systems, Inc. returned -17.6% over the 12 months to 7 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Veeva Systems Inc. is a cloud software company focused on the life sciences industry.
The most recent item we track (Zacks Investment Research, 6 Aug 2026): "Why the Market Dipped But Veeva Systems (VEEV) Gained Today". Veeva Systems (VEEV) rose 2.01% in the recent trading day, closing at $217.80, while the broader market dipped.
Veeva Systems Inc. is a cloud software company focused on the life sciences industry. It provides industry-specific applications that help pharmaceutical, biotechnology, and other healthcare organizations manage customer relationships, clinical operations, quality processes, regulatory content, and commercial activities within a compliant digital environment. The company’s platform is designed to support critical workflows across development, manufacturing, and go-to-market functions, with products that emphasize data integrity, collaboration, and regulatory alignment. Veeva Systems serves a broad range of life sciences customers, from emerging biotech firms to global pharmaceutical companies, and plays a significant role in the modernization of software systems used across healthcare and regulated industries.
CEO Mr. Peter P. Gassner · 7,928 employees · United States · https://www.veeva.com